|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fodde R and Brabletz T: Wnt/beta-catenin
signaling in cancer stemness and malignant behavior. Curr Opin Cell
Biol. 19:150–158. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Polakis P: Wnt signaling and cancer. Genes
Dev. 14:1837–1851. 2000.PubMed/NCBI
|
|
4
|
Maretto S, Cordenonsi M, Dupont S,
Braghetta P, Broccoli V, Hassan AB, Volpin D, Bressan GM and
Piccolo S: Mapping Wnt/beta-catenin signaling during mouse
development and in colorectal tumors. Proc Natl Acad Sci USA.
100:3299–3304. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kawano Y and Kypta R: Secreted antagonists
of the Wnt signalling pathway. J Cell Sci. 116:2627–2634. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Krupnik VE, Sharp JD, Jiang C, Robison K,
Chickering TW, Amaravadi L, Brown DE, Guyot D, Mays G, Leiby K, et
al: Functional and structural diversity of the human Dickkopf gene
family. Gene. 238:301–313. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hirata H, Hinoda Y, Nakajima K, Kawamoto
K, Kikuno N, Kawakami K, Yamamura S, Ueno K, Majid S, Saini S, et
al: Wnt antagonist gene DKK2 is epigenetically silenced and
inhibits renal cancer progression through apoptotic and cell cycle
pathways. Clin Cancer Res. 15:5678–5687. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hauer K, Calzada-Wack J, Steiger K,
Grunewald TG, Baumhoer D, Plehm S, Buch T, Prazeres da Costa O,
Esposito I, Burdach S and Richter GH: DKK2 mediates osteolysis,
invasiveness and metastatic spread in Ewing sarcoma. Cancer Res.
73:967–977. 2013. View Article : Google Scholar
|
|
9
|
Matsui A, Yamaguchi T, Maekawa S, Miyazaki
C, Takano S, Uetake T, Inoue T, Otaka M, Otsuka H, Sato T, et al:
DICKKOPF-4 and -2 genes are upregulated in human colorectal cancer.
Cancer Sci. 100:1923–1930. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Roato I, D'Amelio P, Gorassini E, Grimaldi
A, Bonello L, Fiori C, Delsedime L, Tizzani A, De Libero A, Isaia G
and Ferracini R: Osteoclasts are active in bone forming metastases
of prostate cancer patients. PloS One. 3:e36272008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zenzmaier C, Untergasser G, Hermann M,
Dirnhofer S, Sampson N and Berger P: Dysregulation of Dkk-3
expression in benign and malignant prostatic tissue. Prostate.
68:540–547. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kawasaki K, Watanabe M, Sakaguchi M,
Ogasawara Y, Ochiai K, Nasu Y, Doihara H, Kashiwakura Y, Huh NH,
Kumon H and Date H: REIC/Dkk-3 overexpression downregulates
P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces
apoptosis in breast cancer. Cancer Gene Ther. 16:65–72. 2009.
View Article : Google Scholar
|
|
13
|
Yue W, Sun Q, Dacic S, Landreneau RJ,
Siegfried JM, Yu J and Zhang L: Downregulation of Dkk3 activates
beta-catenin/TCF-4 signaling in lung cancer. Carcinogenesis.
29:84–92. 2008. View Article : Google Scholar
|
|
14
|
Zhu J, Zhang S, Gu L and Di W: Epigenetic
silencing of DKK2 and Wnt signal pathway components in human
ovarian carcinoma. Carcinogenesis. 33:2334–2343. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
de la Taille A, Rubin MA, Chen MW,
Vacherot F, de Medina SG, Burchardt M, Buttyan R and Chopin D:
Beta-catenin-related anomalies in apoptosis-resistant and
hormone-refractory prostate cancer cells. Clin Cancer Res.
9:1801–1807. 2003.PubMed/NCBI
|
|
16
|
Liu Z, Rebowe RE, Wang Z, Li Y, Wang Z,
DePaolo JS, Guo J, Qian C and Liu W: KIF3a promotes proliferation
and invasion via Wnt signaling in advanced prostate cancer. Mol
Cancer Res. 12:491–503. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen G, Shukeir N, Potti A, Sircar K,
Aprikian A, Goltzman D and Rabbani SA: Up-regulation of Wnt-1 and
beta-catenin production in patients with advanced metastatic
prostate carcinoma: Potential pathogenetic and prognostic
implications. Cancer. 101:1345–1356. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Verras M and Sun Z: Roles and regulation
of Wnt signaling and beta-catenin in prostate cancer. Cancer Lett.
237:22–32. 2006. View Article : Google Scholar
|
|
19
|
Lu W, Tinsley HN, Keeton A, Qu Z, Piazza
GA and Li Y: Suppression of Wnt/beta-catenin signaling inhibits
prostate cancer cell proliferation. Eur J Pharmacol. 602:8–14.
2009. View Article : Google Scholar
|
|
20
|
Davies G, Jiang W and Mason M: Cell-cell
adhesion molecules and signaling intermediates and their role in
the invasive potential of prostate cancer cells. J Urol.
163:985–992. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Whitaker HC, Girling J, Warren AY, Leung
H, Mills IG and Neal DE: Alterations in beta. catenin expression
and localization in prostate cancer. Prostate. 68:1196–1205. 2008.
View Article : Google Scholar : PubMed/NCBI
|
